A multicenter, real-world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus
EJHaem
.
2022 Jun 2;3(3):734-738.
doi: 10.1002/jha2.474.
eCollection 2022 Aug.
Authors
Christopher Dittus
1
,
Natalie Grover
1
,
Tarsheen Sethi
2
,
Jonathon B Cohen
3
,
Alfredo Voloschin
3
,
Janhvi Rabadey
1
,
Xianming Tan
4
1
,
Anne Beaven
1
,
Steven I Park
5
Affiliations
1
Division of Hematology University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.
2
Division of Hematology Yale University New Haven Connecticut USA.
3
Department of Hematology and Medical Oncology Emory University-Winship Cancer Institute Atlanta Georgia USA.
4
Department of Biostatistics University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.
5
Atrium Health Levine Cancer Institute Charlotte North Carolina USA.
PMID:
36051081
PMCID:
PMC9421958
DOI:
10.1002/jha2.474
No abstract available
Keywords:
HIV; central nervous system lymphoma; chemotherapy; non‐Hodgkin lymphoma; outcomes.
Grants and funding
UL1 TR001863/TR/NCATS NIH HHS/United States